Abstract
Acute lymphoblastic leukaemia is a highly heterogeneous malignancy characterised by various genomic alterations that influence disease progression and therapeutic outcomes. Gene fusions involving the immunoglobulin heavy chain gene represent a complex and diverse category. These fusions often result in enhancer hijacking, upregulation of partner proto-oncogenes and contribute to leukemogenesis. This review highlights the mechanisms underlying IGH gene fusions, the critical role they play in ALL pathogenesis, and current detection technologies.
Original language | English |
---|---|
Article number | 99 |
Journal | npj Precision Oncology |
Volume | 9 |
Issue number | 1 |
DOIs | |
Publication status | Published or Issued - Dec 2025 |
ASJC Scopus subject areas
- Oncology
- Cancer Research